Regular review is required after lung cancer treatment. The purpose of review is to monitor the efficacy of treatment and to detect the recurrence and metastasis of tumor at an early stage. The examination is mainly based on imaging examination. For early and mid-stage lung cancer, after comprehensive treatment including surgery, it is generally recommended to review every 3 months for 2 years after treatment, and every 2 to 5 years after treatment.
For early and mid-stage lung cancer after comprehensive treatment including surgery, it is generally recommended to review every 3 months within 2 years, every 6 months within 2 to 5 years, and every 1 year after 5 years.
After 5 years, the review should be done every 1 year.